Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adultsZachary S. Wallace, Hyon K. Choi, Claire Cook et al.|Annals of the Rheumatic Diseases|2023Cited by 95
The clinical outcomes and healthcare resource utilization in IgG4-related disease: a claims-based analysis of commercially insured adults in the United StatesZachary S. Wallace, Hyon K. Choi, Ekaterina Smolkina et al.|Lara D. Veeken|2024Cited by 9
First-Time Users of Advanced Therapies Among Adult Patients with Persistent or Chronic Primary Immune Thrombocytopenia: Patient Characteristics, Treatment Switching Patterns, and Clinical OutcomesDavid J. Kuter, Natalia Petruski‐Ivleva, Brad Ward et al.|Blood|2023Cited by 0
EPH85 Clinical Burden of GM2 Gangliosidoses in the United States (US): A Retrospective Observational Cohort Study Using Electronic Health Records (EHR)M.B. Rodríguez, Cynthia J. Tifft, Natalia Petruski‐Ivleva et al.|Value in Health|2023Cited by 0
EE225 Burden of Chronic Obstructive Pulmonary Disease (COPD) Healthcare Costs in Patients with Moderate-to-Severe DiseaseRobert Lubwama, WH Cheng, E. Mayen Herrera et al.|Value in Health|2024Cited by 0